UBS Group’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.74M | Sell |
|
|||||
|
2025
Q1 | $5.45M | Buy |
|
|||||
|
2024
Q4 | $4M | Buy |
|
|||||
|
2024
Q3 | $1.22M | Buy |
|
|||||
|
2024
Q2 | $777K | Sell |
|
|||||
|
2024
Q1 | $4.55M | Buy |
|
|||||
|
2023
Q4 | $2.98M | Buy |
|
|||||
|
2023
Q3 | $1.65M | Sell |
|
|||||
|
2023
Q2 | $4.55M | Sell |
|
|||||
|
2023
Q1 | $4.94M | Buy |
|
|||||
|
2022
Q4 | $3.96M | Sell |
|
|||||
|
2022
Q3 | $3.74M | Buy |
|
|||||
|
2022
Q2 | $842K | Sell |
|
|||||
|
2022
Q1 | $6.24M | Sell |
|
|||||
|
2021
Q4 | $8.45M | Buy |
|
|||||
|
2021
Q3 | $202K | Sell |
|
|||||
|
2021
Q2 | $369K | Sell |
|
|||||
|
2021
Q1 | $2.01M | Sell |
|
|||||
|
2020
Q4 | $2.34M | Buy |
|
|||||
|
2020
Q3 | $1.24M | Sell |
|
|||||
|
2020
Q2 | $1.22M | Sell |
|
|||||
|
2020
Q1 | $1.23M | Sell |
|
|||||
|
2019
Q4 | $4.23M | Buy |
|
|||||
|
2019
Q3 | $2.35M | Buy |
|
|||||
|
2019
Q2 | $921K | Buy |
|
|||||
|
2019
Q1 | $179K | Sell |
|
|||||
|
2018
Q4 | $1.15M | Buy |
|
|||||
|
2018
Q3 | $1.32M | Buy |
|
|||||
|
2018
Q2 | $714K | Buy |
|
|||||
|
2018
Q1 | $104K | Sell |
|
|||||
|
2017
Q4 | $180K | Buy |
|
|||||
|
2017
Q3 | $168K | Buy |
|
|||||
|
2017
Q2 | $12K | Sell |
|
|||||
|
2017
Q1 | $13K | Sell |
|
|||||
|
2016
Q4 | $202K | Buy |
|
|||||
|
2016
Q3 | $22K | Sell |
|
|||||
|
2016
Q2 | $162K | Buy |
|
|||||
|
2016
Q1 | $76K | Sell |
|
|||||
|
2015
Q4 | $79K | Buy |
|
|||||
|
2015
Q3 | $80K | Buy |
|
|||||
|
2015
Q2 | $44K | Sell |
|
|||||
|
2015
Q1 | $61K | Sell |
|
|||||
|
2014
Q4 | $560K | Buy |
|